All 266 IBB Holdings
The IBB ETF, or iShares Nasdaq Biotechnology ETF, is an investment product that allows you to invest in a diverse range of companies within the biotechnology sector. Biotechnology involves the use of living organisms or their components to create new products, such as medicines and therapies for various diseases. The ETF aims to track the performance of the Nasdaq Biotechnology Index, which consists of leading biotech companies listed on the Nasdaq Stock Market.
**Charts show 1 year
| Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
|---|---|---|---|---|---|---|
| 1 | VRTX |   | 10.75% | United States | $91b | Biotechnology |
| 2 | REGN |  | 9.68% | United States | $80b | Biotechnology |
| 3 | AMGN |  | 9.4% | United States | $125b | Drug Manufacturers-General |
| 4 | GILD |  | 7.71% | United States | $95b | Drug Manufacturers-General |
| 5 | SGEN |  | 3.74% | United States | $36b | Biotechnology |
| 6 | MRNA |  | 3.6% | United States | $45b | Biotechnology |
| 7 | IQV |  | 3.51% | United States | $42b | Diagnostics & Research |
| 8 | BIIB |  | 3.01% | United States | $39b | Drug Manufacturers-General |
| 9 | MTD |  | 2.78% | United States | $28b | Diagnostics & Research |
| 10 | ALNY |  | 2.6% | United States | $24b | Biotechnology |
| 11 | ARGX |  | 1.65% | United States | $28b | Biotechnology |
| 12 | WAT |  | 1.55% | United States | $16.28b | Diagnostics & Research |
| 13 | ILMN |  | 1.47% | United States | $30b | Diagnostics & Research |
| 14 | BNTX |  | 1.36% | United States | $26b | Biotechnology |
| 15 | BMRN |  | 1.34% | United States | $16.40b | Biotechnology |
| 16 | UTHR |  | 1.28% | United States | $11.24b | Biotechnology |
| 17 | INCY |  | 1.2% | United States | $14.21b | Biotechnology |
| 18 | SRPT |  | 1.18% | United States | $9.54b | Biotechnology |
| 19 | GMAB |  | 1.16% | United States | $27b | Biotechnology |
| 19 | NBIX |  | 1.16% | United States | $9.84b | Drug Manufacturers-Specialty & Generic |
| 21 | BGNE |  | 1.03% | United States | $22b | Biotechnology |
| 22 | CRL |  | 0.93% | United States | $10.68b | Diagnostics & Research |
| 22 | MEDP |  | 0.93% | United States | $7.86b | Diagnostics & Research |
| 24 | NTRA |  | 0.85% | United States | $5.12b | Diagnostics & Research |
| 25 | INSM |  | 0.79% | United States | $3.01b | Biotechnology |
| 26 | KRTX |  | 0.72% | United States | $6.90b | Biotechnology |
| 27 | IMCR |  | 0.67% | United States | $3.17b | Biotechnology |
| 28 | HALO |  | 0.64% | United States | $5.82b | Biotechnology |
| 28 | EXEL |  | 0.64% | United States | $6.39b | Biotechnology |
| 30 | IMGN |  | 0.61% | United States | $4.03b | Biotechnology |
| 31 | IONS |  | 0.6% | United States | $5.92b | Biotechnology |
| 32 | RGEN |  | 0.58% | United States | $9.53b | Medical Instruments & Supplies |
| 33 | BRKR |  | 0.57% | United States | $10.08b | Medical Devices |
| 34 | BPMC |  | 0.56% | United States | $3.96b | Biotechnology |
| 35 | ITCI |  | 0.53% | United States | $5.89b | Drug Manufacturers-Specialty & Generic |
| 35 | RXDX |  | 0.53% | United States | Biotechnology | |
| 37 | ASND |  | 0.52% | United States | $5.15b | Biotechnology |
| 38 | LEGN |  | 0.5% | United States | $12.64b | Biotechnology |
| 39 | RETA |  | 0.44% | United States | $5.32b | Biotechnology |
| 39 | VRNA |  | 0.44% | United States | $1.74b | Biotechnology |
| 41 | CYTK |  | 0.43% | United States | $3.17b | Biotechnology |
| 42 | SYNH |  | 0.39% | United States | $4.38b | Diagnostics & Research |
| 43 | ISEE |  | 0.38% | United States | Biotechnology | |
| 44 | CRSP |  | 0.35% | United States | $4.51b | Biotechnology |
| 44 | ALKS |  | 0.35% | United States | $4.81b | Drug Manufacturers-Specialty & Generic |
| 46 | KRYS |  | 0.32% | United States | $3.33b | Biotechnology |
| 47 | MDGL |  | 0.31% | United States | $3.72b | Biotechnology |
| 47 | APLS |  | 0.31% | United States | $2.87b | Biotechnology |
| 49 | MRTX |  | 0.27% | United States | $1.76b | Biotechnology |
| 50 | PCVX |  | 0.26% | United States | $3.85b | Biotechnology |